Stevenson, Wong & Co. advised Grand Brilliance Group Holdings Limited (“Grand Brilliance”, Stock Code: 8372) as its Hong Kong legal advisers on its initial public offering (“IPO”) on GEM of Hong Kong Stock Exchange.
The IPO comprised an issue of a total of 168 million shares priced at HK$0.335 per share, raising gross proceeds of approximately HK$56.3 million.
Grand Brilliance is an established medical device distributor with over 19 years of experience in the medical device market in Hong Kong. Grand Brilliance’s customers include private and public hospitals, private clinics, non-profit organisations and universities in Hong Kong.
The SW team was led by corporate partners Hank Lo and Cornelia Chu and senior associate Terence Lau, supported by registered foreign lawyer Matthew Chan and paralegal David Leung.
The Sole Sponsor is Guotai Junan Capital Limited. The Sole Global Coordinator is Guotai Junan Securities (Hong Kong) Limited.
From left to right: Matthew Chan (registered foreign lawyer); Terence Lau (senior associate); Ms. Wong Bik Kwan Bikie (the chairman and CEO of Grand Brilliance); Hank Lo (partner)